Diazoxide

Hyperstat, Proglycem (diazoxide) is a small molecule pharmaceutical. Diazoxide was first approved as Hyperstat on 1982-01-01. It is used to treat hypoglycemia and malignant hypertension in the USA. It is known to target ATP-sensitive inward rectifier potassium channel 8, ATP-sensitive inward rectifier potassium channel 11, and nicotinamide phosphoribosyltransferase.